We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCID icon
201
PUT
Lucid Motors
LCID
$2.61B
$154K 0.01%
510
-8,470
-94% -$1.61M
ACAQ
202
DELISTED
Athena Consumer Acquisition Corp.
ACAQ
$152K 0.01%
+15,135
New +$152K
DMYS.WS
203
DELISTED
dMY Technology Group, Inc. VI Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
DMYS.WS
$148K 0.01%
414,454
+285,326
+221% +$145K
SDACW
204
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$143K 0.01%
1,781,597
+636,855
+56% +$123K
NVACR
205
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$142K 0.01%
1,214,826
+98,573
+9% +$12.9K
ALNY icon
206
PUT
Alnylam Pharmaceuticals
ALNY
$29.2B
$141K 0.01%
5,500
-5,000
-48% -$709K
ASPCW
207
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$141K 0.01%
539,576
+73,252
+16% +$32.6K
SLAMW
208
DELISTED
Slam Corp. warrant
SLAMW
$139K 0.01%
704,051
+469,441
+200% +$146K
APLS
209
DELISTED
Apellis Pharmaceuticals
APLS
$135K 0.01%
2,992
+1,762
+143% +$80.3K
GENQW
210
DELISTED
Genesis Unicorn Capital Corp. Warrants
GENQW
$133K 0.01%
+981,600
New +$158K
SBII
211
DELISTED
Sandbridge X2 Corp.
SBII
$132K 0.01%
+13,510
New +$132K
FTPAW
212
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
$129K 0.01%
+643,112
New +$203K
GET
213
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
$129K 0.01%
79,932
MSFT icon
214
Microsoft
MSFT
$3.75T
$128K 0.01%
+500
New +$136K
DJTWW
215
Trump Media & Technology Group Warrants
DJTWW
$774M
$126K 0.01%
22,010
-23,545
-52% -$278K
ASAQ.WS
216
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
$121K 0.01%
1,515,168
+52,888
+4% +$6.17K
VAQC
217
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$118K 0.01%
12,000
-689
-5% -$6.75K
ZTAQW
218
DELISTED
Zimmer Energy Transition Acquisition Corp. Warrants
ZTAQW
$117K 0.01%
356,080
+54,473
+18% +$20.4K
KAHC.WS
219
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$117K 0.01%
324,981
+224,981
+225% +$116K
MBI icon
220
MBIA
MBI
$262M
$112K 0.01%
+9,108
New +$120K
PEGRW
221
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$112K 0.01%
799,700
+30
+0% +$9
LUXAW
222
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$106K 0.01%
708,408
+10,314
+1% +$2.59K
CCJ icon
223
PUT
Cameco
CCJ
$42.5B
$105K 0.01%
+20,500
New +$517K
MSOS icon
224
AdvisorShares Pure US Cannabis ETF
MSOS
$876M
$104K 0.01%
10,000
-16,824
-63% -$250K
VSEEW
225
DELISTED
VSEE HEALTH INC WTS 29
VSEEW
$103K 0.01%
935,137
-326,393
-26% -$46.6K

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.